| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 6.79e-06 | 270 | 76 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.95e-05 | 410 | 76 | 9 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell-cell junction | 4.01e-05 | 3 | 76 | 2 | GO:0150106 | |
| Pubmed | 9.22e-07 | 76 | 80 | 5 | 27542412 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 22246909 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 14551197 | ||
| Pubmed | NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. | 5.23e-06 | 2 | 80 | 2 | 27551157 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20804738 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31694939 | ||
| Pubmed | Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. | 5.23e-06 | 2 | 80 | 2 | 10318861 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 22204709 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20712008 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17506087 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 12734187 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 5.74e-06 | 420 | 80 | 8 | 28065597 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 14991534 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 18223652 | ||
| Pubmed | Defective vascular morphogenesis and mid-gestation embryonic death in mice lacking RA-GEF-1. | 1.57e-05 | 3 | 80 | 2 | 17826737 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 23264219 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 23651034 | ||
| Pubmed | A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. | 1.57e-05 | 3 | 80 | 2 | 19494296 | |
| Pubmed | Angiogenic squamous dysplasia-like phenomenon in oral epithelial precursor lesions. | 1.57e-05 | 3 | 80 | 2 | 19661015 | |
| Pubmed | Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis. | 1.57e-05 | 3 | 80 | 2 | 24971370 | |
| Pubmed | The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. | 1.57e-05 | 3 | 80 | 2 | 15085134 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 FAP EOGT MAP1B ARSK NAGLU LRP1 ITGA1 ENG TMEM38B SDF2 NUP35 | 1.88e-05 | 1201 | 80 | 12 | 35696571 |
| Pubmed | 2.50e-05 | 250 | 80 | 6 | 33536335 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | USP34 FAP EOGT SBF1 ARSK TTC21A NAGLU LRP1 OAS1 ITGA1 ENG SDF2 SEC23A | 2.56e-05 | 1451 | 80 | 13 | 30550785 |
| Pubmed | Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia. | 3.13e-05 | 4 | 80 | 2 | 25384343 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 22271899 | ||
| Pubmed | The role of FREM2 and FRAS1 in the development of congenital diaphragmatic hernia. | 3.13e-05 | 4 | 80 | 2 | 29618029 | |
| Pubmed | Essential role for Galpha13 in endothelial cells during embryonic development. | 3.13e-05 | 4 | 80 | 2 | 15919816 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 12466202 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 24491438 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 17603494 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 9626495 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 26078569 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 26739051 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 11470398 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 36692953 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 32735820 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 15967814 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 27704157 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | NEXMIF ALDH16A1 TTC21A NAGLU DNAH2 GLIPR1L2 CHD6 IGSF9B DHX9 | 4.93e-05 | 736 | 80 | 9 | 29676528 |
| Pubmed | Vascular and mesenchymal factors during heart development: a chronological study. | 5.20e-05 | 5 | 80 | 2 | 22395512 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 12941632 | ||
| Pubmed | 6.57e-05 | 591 | 80 | 8 | 15231748 | ||
| Pubmed | 7.46e-05 | 777 | 80 | 9 | 35844135 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 31972158 | ||
| Pubmed | MAIT cell activation augments adenovirus vector vaccine immunogenicity. | 7.79e-05 | 6 | 80 | 2 | 33510029 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 25745180 | ||
| Pubmed | Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont. | 7.79e-05 | 6 | 80 | 2 | 36034693 | |
| Pubmed | Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells. | 7.79e-05 | 6 | 80 | 2 | 11167825 | |
| Pubmed | Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix. | 7.79e-05 | 6 | 80 | 2 | 28348210 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 23575436 | ||
| Pubmed | Dynamic changes in endoglin expression in the developing mouse heart. | 7.79e-05 | 6 | 80 | 2 | 33373688 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 17244818 | ||
| Pubmed | Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling. | 7.79e-05 | 6 | 80 | 2 | 23886837 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 25103237 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 16952463 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 25527710 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 10858437 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 23266827 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 25930096 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 7719021 | ||
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 1.35e-04 | 43 | 80 | 3 | 18804439 | |
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 19559055 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 27032818 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 32270034 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 18924607 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 25377550 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 19705428 | ||
| Pubmed | RBFOX2 is required for establishing RNA regulatory networks essential for heart development. | 1.45e-04 | 8 | 80 | 2 | 35137168 | |
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 23658024 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 16926294 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MALT1 EOGT SGMS1 MAP1B DTNA TTC21A LRP1 MACF1 CHD6 IGSF9B TECTA TRRAP | 1.48e-04 | 1489 | 80 | 12 | 28611215 |
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 26829768 | ||
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 19705443 | ||
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 38424240 | ||
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 20737513 | ||
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 23744273 | ||
| Pubmed | 2.32e-04 | 10 | 80 | 2 | 26897459 | ||
| Pubmed | 2.32e-04 | 10 | 80 | 2 | 9119362 | ||
| Pubmed | 2.32e-04 | 10 | 80 | 2 | 20176734 | ||
| Pubmed | 2.32e-04 | 10 | 80 | 2 | 38451068 | ||
| Pubmed | Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. | 2.32e-04 | 10 | 80 | 2 | 21282641 | |
| Pubmed | Sox18 induces development of the lymphatic vasculature in mice. | 2.32e-04 | 10 | 80 | 2 | 18931657 | |
| Pubmed | 2.84e-04 | 11 | 80 | 2 | 19776009 | ||
| Pubmed | Endoglin is required in Pax3-derived cells for embryonic blood vessel formation. | 2.84e-04 | 11 | 80 | 2 | 26481065 | |
| Pubmed | Three-dimensional cartography of hematopoietic clusters in the vasculature of whole mouse embryos. | 2.84e-04 | 11 | 80 | 2 | 20876651 | |
| Pubmed | 2.84e-04 | 11 | 80 | 2 | 15548578 | ||
| Pubmed | 14-3-3epsilon controls multiple developmental processes in the mouse heart. | 2.84e-04 | 11 | 80 | 2 | 27580238 | |
| Pubmed | Immunolocalization of extracellular matrix components and integrins during mouse liver development. | 2.84e-04 | 11 | 80 | 2 | 15368439 | |
| Pubmed | Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. | 2.84e-04 | 11 | 80 | 2 | 10196361 | |
| Pubmed | 2.84e-04 | 11 | 80 | 2 | 15499555 | ||
| Pubmed | Nuclear export factor family protein participates in cytoplasmic mRNA trafficking. | 2.84e-04 | 11 | 80 | 2 | 16014633 | |
| Pubmed | 3.24e-04 | 257 | 80 | 5 | 16335952 | ||
| Pubmed | cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. | 3.40e-04 | 12 | 80 | 2 | 29176737 | |
| Pubmed | A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. | 3.40e-04 | 12 | 80 | 2 | 35099607 | |
| Pubmed | 3.40e-04 | 12 | 80 | 2 | 15322537 | ||
| Pubmed | 3.40e-04 | 12 | 80 | 2 | 19095005 | ||
| Pubmed | Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. | 3.40e-04 | 12 | 80 | 2 | 20223757 | |
| Pubmed | IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development. | 3.40e-04 | 12 | 80 | 2 | 28794449 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.68e-04 | 146 | 80 | 4 | 23892456 | |
| Interaction | GLUD2 interactions | 8.82e-06 | 34 | 78 | 4 | int:GLUD2 | |
| Interaction | PLAUR interactions | 1.40e-05 | 135 | 78 | 6 | int:PLAUR | |
| Interaction | ATOH1 interactions | 1.46e-05 | 80 | 78 | 5 | int:ATOH1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.86e-07 | 181 | 81 | 6 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 187 | 81 | 6 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 187 | 81 | 6 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 187 | 81 | 6 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 187 | 81 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.23e-06 | 188 | 81 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-06 | 192 | 81 | 6 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.71e-06 | 199 | 81 | 6 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 81 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-06 | 118 | 81 | 5 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-06 | 118 | 81 | 5 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 162 | 81 | 5 | 465cb483f41023d6125ea147e16f404d8e8dc9bb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 167 | 81 | 5 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.56e-05 | 172 | 81 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 173 | 81 | 5 | 51328a60ffaf34fa0f7df6084d348b5efc9917f5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 173 | 81 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.60e-05 | 173 | 81 | 5 | b77cd5dbda3a206922f20224f4e10a3bf712f7db | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.94e-05 | 180 | 81 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 180 | 81 | 5 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-05 | 180 | 81 | 5 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 81 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 181 | 81 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 183 | 81 | 5 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.16e-05 | 184 | 81 | 5 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 185 | 81 | 5 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-05 | 187 | 81 | 5 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 187 | 81 | 5 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-05 | 187 | 81 | 5 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-05 | 187 | 81 | 5 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.45e-05 | 189 | 81 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.45e-05 | 189 | 81 | 5 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 190 | 81 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.58e-05 | 191 | 81 | 5 | 88cb6f828407845918c946f8cee5f940cb81800a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-05 | 191 | 81 | 5 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 191 | 81 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-05 | 191 | 81 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.65e-05 | 192 | 81 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.65e-05 | 192 | 81 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 193 | 81 | 5 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 2.71e-05 | 193 | 81 | 5 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 193 | 81 | 5 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.71e-05 | 193 | 81 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.78e-05 | 194 | 81 | 5 | 7b8fe5b702b99aac5bff7de8ac0b5cabb3235b56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 195 | 81 | 5 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.85e-05 | 195 | 81 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.85e-05 | 195 | 81 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-05 | 196 | 81 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 197 | 81 | 5 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 197 | 81 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 197 | 81 | 5 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 197 | 81 | 5 | ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-05 | 197 | 81 | 5 | c747d05bb032abf8dad46ff6f4d1951bbe64b3b4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 197 | 81 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 197 | 81 | 5 | 7bec9c1bc8851064eb229324493b47a31201c83c | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 198 | 81 | 5 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | proximal-Hematologic-Alveolar_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 198 | 81 | 5 | a5deecd8809bc5b38ffda02143598ad0145e2559 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | proximal-Hematologic-Alveolar_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 198 | 81 | 5 | ec0092ef6207e788e2c20ddf007a2f6f6e351d0b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 198 | 81 | 5 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | proximal-3-Hematologic-Alveolar_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 198 | 81 | 5 | a5daf11bf7fe614be9f4a0fc6a4b37b5dce2f6fc | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.22e-05 | 200 | 81 | 5 | 4fb6fd703aca9a992924245105ad99163146a415 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-05 | 200 | 81 | 5 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.22e-05 | 200 | 81 | 5 | b50de1f8c8f598e281951e4587f2d96c11aac836 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 7.29e-05 | 122 | 81 | 4 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 143 | 81 | 4 | 9bfb3674c8f011b9cf928b522777b8d54478db8d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.46e-04 | 146 | 81 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Fos_(IEG+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 57 | 81 | 3 | cb8d23979dc6edcc6c286a497b424f59ce9ad2db | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Fos_(IEG+)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 57 | 81 | 3 | bfb658d85773a1ed968ba1076ab50a79adfb476f | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-04 | 149 | 81 | 4 | f4bee5fdaaa4a1917e403de90e5a62353006df24 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-04 | 151 | 81 | 4 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 1.66e-04 | 151 | 81 | 4 | 9bfb807e1180b31fa9a2c500ce993de9707c070f | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.75e-04 | 153 | 81 | 4 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 154 | 81 | 4 | 692eb053620db86d301b09bf743ab45fccc245be | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 160 | 81 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.07e-04 | 160 | 81 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Control-CD8+_T|World / Disease group and Cell class | 2.07e-04 | 160 | 81 | 4 | f5151f5cf1a4a4a997496e03e48293e4c751d077 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 160 | 81 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.22e-04 | 163 | 81 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 164 | 81 | 4 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; HL60; HT_HG-U133A | 5.05e-06 | 194 | 79 | 7 | 2965_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 5.59e-06 | 197 | 79 | 7 | 1314_DN | |
| Disease | Virus Diseases | 6.90e-06 | 2 | 78 | 2 | C0042769 | |
| Disease | Autoimmune Lymphoproliferative Syndrome | 1.91e-04 | 8 | 78 | 2 | C1328840 | |
| Disease | pulse pressure measurement | USP36 USP34 SGMS1 MAP1B MYO1E WDR7 SETD6 PECAM1 LRP1 GCK ITGA1 VCL | 2.81e-04 | 1392 | 78 | 12 | EFO_0005763 |
| Disease | Long QT Syndrome | 3.74e-04 | 11 | 78 | 2 | C0023976 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.93e-04 | 670 | 78 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 4.48e-04 | 12 | 78 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | salicylurate measurement | 5.28e-04 | 13 | 78 | 2 | EFO_0010532 | |
| Disease | Migraine Disorders | 5.28e-04 | 13 | 78 | 2 | C0149931 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 9.14e-04 | 17 | 78 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 9.32e-04 | 163 | 78 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.20e-03 | 447 | 78 | 6 | C3714756 | |
| Disease | coronary artery calcification | 1.24e-03 | 450 | 78 | 6 | EFO_0004723 | |
| Disease | progression free survival, ovarian serous carcinoma | 1.54e-03 | 22 | 78 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | PR interval | 2.00e-03 | 495 | 78 | 6 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NVNASTYMLRTNHWK | 411 | Q6UWY0 | |
| HVNNSFSTDVYIVMW | 261 | Q5NDL2 | |
| TNKHTQWYYFQVTNM | 201 | Q8NEM8 | |
| HQDVQAMWYFGSAQG | 736 | Q8IZ83 | |
| QNWVFVKESMDSFHY | 46 | A6NHR8 | |
| QNSGFNHWKMAYSLC | 281 | Q9Y5Z6 | |
| HVNSARQYKDLWNMS | 6 | P15336 | |
| NHNMQIWTTGEYSFK | 266 | P17813 | |
| STQHQQWFYFKVSGM | 626 | Q96MI9 | |
| NVTKMGSWGHFNCSY | 261 | P54802 | |
| EGQWSVKTKHQMYSI | 96 | P35557 | |
| MWEHIATFNALGYVQ | 476 | Q96RS6 | |
| TGHFSWKMAKANLYQ | 566 | P23352 | |
| RYHMPVKNSQGFTWN | 556 | O95256 | |
| YFMQQWTGTNKDKAE | 436 | P46821 | |
| HSKQSHFYETFWMNS | 1576 | Q5T1H1 | |
| SWHAEKKMYNFENGS | 136 | Q4G1C9 | |
| TVTLDNNSMWNEFYH | 76 | Q8IWI9 | |
| TGHPFVQYQWFKMNK | 151 | Q9UDY8 | |
| DWHVSGSIQKNTHYM | 271 | Q8TDD5 | |
| NMDYTITMFFHQTWK | 101 | Q9UN88 | |
| VSYMKNQNGTFKDWA | 71 | Q9NUN5 | |
| HVEQMAIDWLTGNFY | 281 | Q07954 | |
| FQHAWSYTNGIDMNA | 701 | Q12809 | |
| TYANMTFQVQWLHAF | 251 | P17181 | |
| SVKDINWMEYLHGFN | 316 | Q9NYQ8 | |
| YQMTSNATQAFWTKQ | 546 | P16284 | |
| WKDMNAFHINYVQSR | 1096 | Q5H8C1 | |
| ISQEMTQGYQHIWSL | 851 | Q96LU7 | |
| TQNHWFTYNETMTVE | 96 | P28066 | |
| TVYAWERGSMKTHFN | 236 | P00973 | |
| GTNYAQKFQGWVTMT | 76 | P23083 | |
| EMSQTGFSAHYSQDW | 376 | P56199 | |
| YHQFQNSADSLQAWM | 4001 | Q9UPN3 | |
| QFWEAMFYGDVQTHI | 681 | O95248 | |
| VMYTYGNKQHNSPTW | 261 | Q9NQ84 | |
| IQSMNYGTIKWFFHV | 21 | Q99572 | |
| GQFGEVWMATYNKHT | 271 | P08631 | |
| WTEMNAIVYHGSQIS | 531 | Q8TD26 | |
| GFWSQVKQHYGVDMS | 206 | Q96LA8 | |
| SNQHQMKEYTSWKSP | 281 | Q9Y4J8 | |
| MKSQGQHWYSSSDKN | 1 | Q92851 | |
| QIFVTMHWSVAQYSQ | 2951 | Q9P225 | |
| KVKWHFNYVSSSQME | 121 | Q9BRL7 | |
| LQEYGSQKTMSFFNW | 181 | A6NIM6 | |
| GRAYWDIMISNHQNS | 36 | P35542 | |
| TEHTGQESYVWKMYQ | 4931 | Q92736 | |
| AHNNMTNYATVWASK | 741 | Q08211 | |
| YGNILKHVMSNTGNW | 196 | Q8NFH5 | |
| KMSQNTQDGYTRNWF | 111 | Q9GZY0 | |
| GTVKMSWSHAFYDSQ | 521 | Q9NP80 | |
| NLSWYHGSDNLLKQM | 1026 | Q86VV8 | |
| MSVEYSQSWGHFQNR | 191 | Q86YT9 | |
| HNFKMESSNYRNVWP | 876 | Q5QGS0 | |
| IHSYQSYVWNNMVSK | 476 | Q96PZ0 | |
| IFNTYGQMANWQLIH | 281 | Q8TBK2 | |
| MDAVQNWGKQYDVHS | 546 | P14410 | |
| KVNPSQTHNNMYAWG | 721 | Q15436 | |
| VHGMAQPSQNNYWKA | 176 | Q99470 | |
| SQEVVKHWTNTYAGM | 86 | Q0VFZ6 | |
| SNSTAWQAYNAGVKM | 546 | Q5BKX6 | |
| QVDFQAMWYSDQNHG | 721 | Q12884 | |
| VQSNGTHIMYKNTLW | 1861 | O75443 | |
| GKAWNMFASKAYIHQ | 411 | Q9UJT1 | |
| MYFSDATKTKNGWAN | 376 | A0JNW5 | |
| MNGYHKFHQDSWSSK | 226 | P0CB47 | |
| HATSQYMWGVQDTDL | 106 | P21580 | |
| QFTEHFNNMSYWVRS | 881 | Q13905 | |
| LMLDQQYDTFHNGSW | 116 | Q9UPX0 | |
| AYEHFETMKNQWIDN | 691 | P18206 | |
| THANSYYKNGWIVMI | 131 | Q9NVV0 | |
| WYHTMANQQVLKEAS | 346 | Q86VZ5 | |
| KDSTWGQSAIYHMVQ | 1056 | Q8NDW8 | |
| QNFSKSWHDMQTTTA | 81 | Q16890 | |
| QGQSMHFSNYRITWI | 126 | Q6GV28 | |
| FQQFGSSYDTHWITM | 931 | Q70CQ2 | |
| HGGYVKYWQSNMNNV | 181 | Q9C0J8 | |
| TYSNTDSHISFWQMN | 1411 | Q9Y4E6 | |
| YLFNGVKKMGNHWNS | 681 | Q8NA31 | |
| YVTCSQNWEAMGNHF | 2476 | Q9Y4A5 | |
| YVKASNGQWYQMNDS | 386 | Q9P275 | |
| MGSKGVYQYHWQSHN | 1 | Q12965 |